Skip to content
2000
Volume 16, Issue 1
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Fragment-based drug discovery (FBDD) has caused a revolution in the process of drug discovery and design, with many FBDD leads being developed into clinical trials or approved in the past few years. Compared with traditional high-throughput screening, it displays obvious advantages such as efficiently covering chemical space, achieving higher hit rates, and so forth. In this review, we focus on the most recent developments of FBDD for improving drug discovery, illustrating the process and the importance of FBDD. In particular, the computational strategies applied in the process of FBDD and molecular-docking programs are highlighted elaborately. In most cases, docking is used for predicting the ligand–receptor interaction modes and hit identification by structurebased virtual screening. The successful cases of typical significance and the hits identified most recently are discussed.

Loading

Article metrics loading...

/content/journals/cpb/10.2174/1389201015666141122204532
2015-01-01
2025-07-11
Loading full text...

Full text loading...

/content/journals/cpb/10.2174/1389201015666141122204532
Loading

  • Article Type:
    Research Article
Keyword(s): Drug candidate; drug design; drug discovery; FBDD; molecular docking; virtual screening
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test